Embecta Corp.

EMBC Healthcare Medical Instruments & Supplies

Embecta Corp.’s revenue for fiscal 2025 (year ended September 2025) was $1.1 billion, down 3.80% from fiscal 2024. In the quarter to June 2026, revenue fell 8.05%, EPS fell 53.9%, free cash flow fell 49.6% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.27 0.18 −2.79%
Market cap
$365.5M
P/E
4.2×
Fwd P/E
3.8×
Dividend yield
5.10%
F-score
7/9
Altman Z
1.84
Beneish M
−3.11
Dividend safety
56/100

Embecta Corp. (EMBC) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Embecta Corp. (EMBC) trades at a P/E ratio of 4.2×. Over the past ten years it has ranged from 1.5× (May 2026) to 26.7× (August 2023); the current reading is higher than 22% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 8.7× (17.12%)
FY2024 10.4× (12.55%)
FY2023 11.9× 61.38%
FY2022 7.4× 41.85%
FY2021 5.2× 0.00%
FY2021 5.2× 0.00%
FY2020 5.2× 0.00%
FY2020 5.2× 0.00%
FY2019 5.2× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 2.2× (52.73%)
Mar 2026 4.6× (7.28%)
Dec 2025 5.0× (42.34%)
Sep 2025 8.7× 27.75%
19 more quarters

Against its own ten years

Low 1.5× High 26.7×
Ten-year median 10.1×
Current reading's percentile 22

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on EMBC